98 related articles for article (PubMed ID: 5072367)
1. Inability of isoquinoline derivatives to inhibit virus neuraminidase activity.
Shinkai K; Nishimura T
J Gen Virol; 1972 Aug; 16(2):227-9. PubMed ID: 5072367
[No Abstract] [Full Text] [Related]
2. A QSAR study on influenza neuraminidase inhibitors.
Verma RP; Hansch C
Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of different strains of influenza A virus to the inhibitory effects of 2-deoxy-2,3-dehydro-n-trifluoracetylneuraminic acid (FANA).
Schulman JL; Palese P
Virology; 1975 Jan; 63(1):98-104. PubMed ID: 1167433
[No Abstract] [Full Text] [Related]
4. Haemolysis by Sendai virus: lack of requirement for neuraminidase.
Neurath AR; Vernon SK; Hartzell RW; Rubin BA
J Gen Virol; 1972 Aug; 16(2):245-9. PubMed ID: 4342042
[No Abstract] [Full Text] [Related]
5. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
Sun J; Mei H
Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of influenza and parainfluenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA).
Palese P; Schulman JL; Bodo G; Meindl P
Virology; 1974 Jun; 59(2):490-8. PubMed ID: 4364826
[No Abstract] [Full Text] [Related]
7. [Influence of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid on Myxovirus-neuraminidases and the replication of influenza- and Newcastle disease virus].
Meindl P; Bodo G; Lindner J; Palese P
Z Naturforsch B; 1971 Aug; 26(8):792-7. PubMed ID: 4399278
[No Abstract] [Full Text] [Related]
8. [Use of synthetic inhibitors of neuraminidase and hemagglutinin for studying the functional role of active subunits of membranes of myxo- and paramyxoviruses].
Zakstel'skaia LIa; Molibog EV; Iakhno MA; Evstigneeva NA; Isachenko VA
Vopr Virusol; 1972; 17(2):223-8. PubMed ID: 4337525
[No Abstract] [Full Text] [Related]
9. Enhancement of neuraminidase activity with influenza virus by anti-influenza virus drug.
Fukushima K; Toyoshima S
Keio J Med; 1974 Sep; 23(3):125-36. PubMed ID: 4444089
[No Abstract] [Full Text] [Related]
10. Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design.
Chand P; Babu YS; Bantia S; Chu N; Cole LB; Kotian PL; Laver WG; Montgomery JA; Pathak VP; Petty SL; Shrout DP; Walsh DA; Walsh GM
J Med Chem; 1997 Dec; 40(25):4030-52. PubMed ID: 9406595
[TBL] [Abstract][Full Text] [Related]
11. Temperature optima of neuraminidase activity of influenza viruses.
Golubev DB; Aptekareva MN; Ivanova NA; Bykov SE; Ivannikov YG
Acta Virol; 1973 Jul; 17(4):281-6. PubMed ID: 4148206
[No Abstract] [Full Text] [Related]
12. Biotin-, fluorescein- and 'clickable' conjugates of phospha-oseltamivir as probes for the influenza virus which utilize selective binding to the neuraminidase.
Stanley M; Martin SR; Birge M; Carbain B; Streicher H
Org Biomol Chem; 2011 Aug; 9(16):5625-9. PubMed ID: 21720632
[TBL] [Abstract][Full Text] [Related]
13. The effect of phospholipase C on influenza viruses: limited release of "soluble" V-antigens and of neuraminidase.
Neurath AR; Rubin BA
Life Sci; 1967 Mar; 6(6):575-80. PubMed ID: 4291878
[No Abstract] [Full Text] [Related]
14. Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun C; Zhang X; Huang H; Zhou P
Bioorg Med Chem; 2006 Dec; 14(24):8574-81. PubMed ID: 16979342
[TBL] [Abstract][Full Text] [Related]
15. [Screening based on response surface methodology of multi-fractions traditional Chinese medicine with anti-influenza virus neuraminidase activity: take shuanghuanglian injection as an example].
Qiu LL; Chen LH; Yan D; Zhang P; Tan MR; Li ZM; Xiao XH
Yao Xue Xue Bao; 2012 Apr; 47(4):466-71. PubMed ID: 22799028
[TBL] [Abstract][Full Text] [Related]
16. Anti-influenza virus activity of biflavonoids.
Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
[TBL] [Abstract][Full Text] [Related]
17. [Screening bioactive compounds inhibiting influenza virus from isatidis radix by ultrafiltration mass spectrometry].
Ma LN; Zhang CE; Yan D; Tan MR; Li HB; Zhang LL; Xiong Y; Xiao XH
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):812-6. PubMed ID: 25204170
[TBL] [Abstract][Full Text] [Related]
18. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
Cheng CK; Tsai CH; Shie JJ; Fang JM
Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
[TBL] [Abstract][Full Text] [Related]
20. The inhibitory activity of an isoquinoline derivative on growth of an influenza A virus in tissue culture.
Hobson D; Flockton HI; Gregory MG
Br J Exp Pathol; 1969 Oct; 50(5):494-501. PubMed ID: 5388496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
